Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

WDR92 antibody (AA 122-357) (FITC)

WDR92 Reactivity: Human Host: Rabbit Polyclonal FITC
Catalog No. ABIN7175812
  • Target See all WDR92 Antibodies
    WDR92 (WD Repeat Domain 92 (WDR92))
    Binding Specificity
    • 3
    • 1
    • 1
    • 1
    • 1
    AA 122-357
    Reactivity
    • 7
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Host
    • 8
    Rabbit
    Clonality
    • 8
    Polyclonal
    Conjugate
    • 6
    • 1
    • 1
    This WDR92 antibody is conjugated to FITC
    Application
    Please inquire
    Cross-Reactivity
    Human
    Purification
    >95%, Protein G purified
    Immunogen
    Recombinant Human WD repeat-containing protein 92 protein (122-357AA)
    Isotype
    IgG
    Top Product
    Discover our top product WDR92 Primary Antibody
  • Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4
    Preservative
    ProClin
    Precaution of Use
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    -20 °C,-80 °C
    Storage Comment
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    WDR92 (WD Repeat Domain 92 (WDR92))
    Alternative Name
    WDR92 (WDR92 Products)
    Synonyms
    AI553587 antibody, HZGJ antibody, zgc:110253 antibody, WD repeat domain 92 antibody, WD repeat domain 92 L homeolog antibody, WDR92 antibody, Wdr92 antibody, wdr92 antibody, wdr92.L antibody
    Background

    Background: Seems to act as a modulator of apoptosis.

    Aliases: FLJ31741 antibody, Monad antibody, OTTHUMP00000205522 antibody, WD repeat domain 92 antibody, WD repeat-containing protein 92 antibody, WD repeat-containing protein Monad antibody, Wdr92 antibody, WDR92_HUMAN antibody

    UniProt
    Q96MX6
You are here: